Zwitterionic hydrogels: an in vivo implantation study

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Tissue Engineering

Background:

• Poly(2-hydroxyethyl methacrylate) (polyHEMA) is a widely used hydrogel for biomedical applications.
• Developing advanced hydrogels with enhanced biocompatibility and integration is crucial for implantable devices.
• Zwitterionic polymers offer unique properties that can improve hydrogel performance.

Purpose of the Study:

• To synthesize and characterize zwitterionic hydrogels, specifically poly(sulfobetaine methacrylate) (polySBMA) and poly(carboxybetaine methacrylate) (polyCBMA).
• To evaluate and compare the in vitro and in vivo properties of these zwitterionic hydrogels with polyHEMA.
• To assess the potential of zwitterionic hydrogels as improved alternatives for implantable materials.

Main Methods:

• Preparation of polySBMA, polyCBMA, and poly(CBMA-co-HEMA) hydrogels.
• In vitro assessment of bioadhesion using bovine aortic endothelial cells (BAECs).
• In vivo subcutaneous implantation in animal models to evaluate cytotoxicity, endotoxin levels, cell attachment, capsule formation, vascularity, and foreign body giant cell (FBGC) response.

Main Results:

• PolySBMA and polyCBMA hydrogels exhibited non-cytotoxicity and acceptable endotoxin levels for implantation.
• Reduced cell attachment was observed on zwitterionic hydrogels compared to polyHEMA after one week.
• Improved vascularity within the surrounding capsules was noted for zwitterionic hydrogels after four weeks, with similar capsule thickness and FBGCs compared to polyHEMA.

Conclusions:

• Zwitterionic hydrogels demonstrate healing and integration capabilities comparable to polyHEMA.
• The enhanced vascularity of zwitterionic hydrogels suggests superior tissue integration.
• PolySBMA and polyCBMA hydrogels represent promising biocompatible alternatives to polyHEMA for various implantable applications.